Enhancement of antitumor activity of OK-432 (picibanil) by Triton X-114 phase partitioning.
Hashimoto M, Takashige K, Furuyashiki M, Yoshidome K, Sano R, Kawamura Y, Ijichi S, Morioka H, Koide H, Oku N, Moriya Y, Kusumoto S, Suda Y.
Hashimoto M, et al. Among authors: oku n.
Int Immunopharmacol. 2008 Jan;8(1):12-9. doi: 10.1016/j.intimp.2007.09.021. Epub 2007 Oct 22.
Int Immunopharmacol. 2008.
PMID: 18068095